Global Hereditary Testing Market Size To Worth USD 13.14 Billion By 2032 | CAGR of 7.8%.
Category: HealthcareGlobal Hereditary Testing Market worth USD 13.14 Billion By 2032
According to a research report published by Spherical Insights & Consulting, The Global Hereditary Testing Market size is to grow from USD 6.20 billion in 2022 to USD 13.14 billion by 2032, at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period.
Get more details on this report -
Browse key industry insights spread across 200 pages with 130 Market data tables and figures & charts from the report on the "Global Hereditary Testing Market Size, Share, and COVID-19 Impact Analysis, By Disease Type (Hereditary Cancer Testing and Hereditary Non-cancer Testing), By Technology (Cytogenetic, Biochemical, and Molecular Testing), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2032." Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/hereditary-testing-market
Hereditary testing, also known as genetic testing or DNA testing, is a medical procedure that examines an individual's DNA to identify genetic variations and mutations associated with inherited disorders or diseases. It provides valuable information about a person's risk factors, aids in early detection, and informs medical decisions. Hereditary testing can assess the likelihood of developing conditions like cancer, cardiovascular diseases, or neurological disorders. It also helps determine an individual's response to specific medications, enabling personalized treatment plans. The process involves collecting a sample (blood or saliva) and analyzing it in a laboratory using advanced genetic sequencing technologies. Genetic counseling and professional interpretation of results are crucial in the complex field of hereditary testing.
The breast cancer hereditary testing segment is expected to grow at a CAGR of around 7.9% during the forecast period
Based on the disease type, the global hereditary testing market is segmented into hereditary cancer testing and hereditary non-cancer testing. The breast cancer hereditary testing segment is anticipated to experience substantial growth during the forecast period. This can be attributed to several factors, such as the growing awareness about the genetic predisposition to breast cancer and the importance of early detection among individuals and healthcare providers. The advancements in genetic testing technologies have made it more accessible and accurate, enabling effective identification of gene mutations associated with hereditary breast cancer. Additionally, increased emphasis on personalized medicine and targeted therapies for breast cancer treatment further drives the demand for hereditary testing. The growing prevalence of breast cancer and the potential for preventive interventions based on genetic risk assessment also contribute to the expected significant growth in the breast cancer hereditary testing segment.
The molecular testing segment is expected to grow at a CAGR of around 7.6% during the forecast period
Based on the technology, the global hereditary testing market is segmented into cytogenetic, biochemical, and molecular testing. The molecular testing segment is projected to witness substantial growth during the forecast period. The molecular testing offers high sensitivity and specificity in detecting genetic variations and mutations, making it a valuable tool in diagnosing hereditary conditions. The advancements in molecular biology techniques, such as PCR and NGS, have improved the efficiency and accuracy of molecular testing, making it more accessible and cost-effective. Moreover, the increasing prevalence of genetic disorders and the growing demand for personalized medicine drive the adoption of molecular testing. Additionally, the development of targeted therapies and precision medicine approaches further fuels the demand for molecular testing in the forecast period.
North America is predicted to grow at a significant CAGR of around 8.2% over the projected period
Get more details on this report -
Based on region, North America is projected to experience substantial growth in the hereditary testing market during the forecast period. The region has a strong healthcare infrastructure and a high level of awareness about genetic testing among both healthcare providers and the general population. Moreover, North America is home to several key players and innovators in the field of hereditary testing, leading to advancements in technology and test offerings. Additionally, the region has favorable reimbursement policies and a robust research ecosystem, which encourages the adoption and expansion of hereditary testing services. The increasing prevalence of genetic disorders and the growing demand for personalized medicine further drive the market growth in North America.
Some of the major players in the global hereditary testing market include Myriad Genetics, Inc., Invitae Corporation, Illumina, Inc., Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, Coopersurgical, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Twist Bioscience, SOPHiA GENETICS, Fulgent Genetics, MedGenome, and CENTOGENE N.V.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global hereditary testing market based on the below-mentioned segments:
Hereditary Testing Market, By Disease Type
- Hereditary Cancer Testing
- Hereditary Non-cancer Testing
Hereditary Testing Market, By Technology
- Cytogenetic
- Biochemical
- Molecular Testing
Hereditary Testing Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?